NCT07436663

Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2026-02-01Est. Completion: 2027-11-01

Enrollment target: 150 participants

Locations

Tanta University, Tanta, Elgharbeya, Egypt

Contact

Mai Aboelyazed Elgebaly, Associate Lecturerdr.mai.elgebaly@gmail.com +0201061412257

Mai Aboelyazed Elgebaly, Associate Lecturermai.elgebaly@deltauniv.edu.eg +201115064114

Other microbiome trials you might be interested in

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive CisplatinPhase 3Recruiting

Locally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell CarcinomaLocally Advanced Oral Cavity Squamous Cell CarcinomaLocally Advanced Oropharyngeal Squamous Cell Carcinoma

This phase III trial compares cetuximab to chemotherapy, carboplatin and paclitaxel, with intensity modulated radiation …

Birmingham, United StatesEst. completion Nov 30, 2035

View Trial →

Decision Support for ChemopreventionRecruiting

Breast Cancer

The purpose of this study is to find out whether electronic tools that provide information and reminders to people at hi…

New York, United StatesEst. completion Sep 2028

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.